MentionFox
Home › funding signals › Conexeu Sciences Inc.
Form D · on the record

Conexeu Sciences Inc. — $45K Form D filing, May 2026

Conexeu Sciences Inc. filed a Form D with the Securities and Exchange Commission on 2026-05-21.

Conexeu Sciences Inc. filed a Form D notice of an exempt securities offering with the SEC on May 21, 2026. Conexeu Sciences Inc. trades on Nasdaq as CNXU. The filing reports $45K sold. Its industry group is Biotechnology. It names DAVID BOGART (Director), MILES HARRISON (Executive Officer, Director), AARON FARBERG (Director) (SEC Form D, May 21, 2026).

Sell to companies like Conexeu Sciences Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

137 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Linework USA INC.$1.2BAI and software
Linework USA INC.$326MAI and software
Pathos AI, Inc.$238MBiotech
Galvanize Therapeutics, Inc.$136MBiotech
Tractian Inc.$106MAI and software
Check one company free All companies that raised this week

5 more Biotechnology raises within 90 days of this one ↓

Is this your company?

Key facts

Run the free check on Conexeu Sciences Inc. →

Conexeu Sciences Inc.

New Form D on file · 2026-05-21 · the record

$45K
raise on the record
D
filing
1
investors in
NEVADA
based
Open the record →

What the record says

FilingForm D
Filed2026-05-21
Industry groupBiotechnology
Entity typeCorporation
Incorporated inNEVADA
Year formed2022
BasedRENO, NEVADA
CIK2066836
Accession0002060755-26-000028

Pitching, partnering or investing alongside them? See who really runs and owns Conexeu Sciences Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Conexeu Sciences Inc., from the filings we hold.

More raises like this

Biotechnology raises filed within 90 days of this one, largest first.

What do you want to do with Conexeu Sciences Inc.?

Get the full cited report on Conexeu Sciences Inc.

What the filing shows about Conexeu Sciences Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 9 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Conexeu Sciences Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Conexeu Sciences Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Conexeu Sciences Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Conexeu Sciences Inc.'s address as 50 West Liberty Street, Suite 880, Reno, NV 89501.

What the filing says

  • Offered: $44,700. Sold: $44,700. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: May 14, 2026. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “Total Offering Amount represents the price of 11,175 common shares at a deemed price of $4.00 per share.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Conexeu Sciences Inc. See pricing

Is Conexeu Sciences Inc. a real, registered company?

Conexeu Sciences Inc. is a registered filer with the SEC (CIK 2066836) and has filed since 2025-05-09. 17 filings are on record, the latest on 2026-09-29.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Conexeu Sciences Inc.?

Conexeu Sciences Inc.'s Form D of 2026-05-21 names David Bogart, Miles Harrison, Aaron Farberg and 6 more as its officers, directors or promoters.

How much has Conexeu Sciences Inc. raised?

Its new offerings report $5.86M sold across 16 offerings, as its own filings state.

Filing history · 19 filings on this registrant
Form D · 2025-05-09 · $1.29MForm D · 2025-06-13 · $1KForm D/A, amended · 2025-07-02 · $1.29MForm D · 2025-11-13 · $2.92MForm D · 2025-11-20 · $202KForm D · 2026-02-04 · $810KForm D · 2026-02-27 · $467Form D · 2026-03-23 · $45KForm D · 2026-04-01Form D · 2026-05-21 · $45K · this pageForm D · 2026-05-21 · $543Form D · 2026-06-10 · $23KForm D/A, amended · 2026-06-12 · $2KForm D · 2026-06-30 · $86KForm D · 2026-06-30 · $203Form D · 2026-07-31 · $63KForm D · 2026-08-31 · $89KForm D · 2026-09-15 · $252KForm D · 2026-09-29 · $31K 2025-05-09 2026-09-29

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Biotechnology · by week
This raise, $45K, filed week of May 18

Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $45K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Conexeu Sciences Inc.?

What the filing shows about Conexeu Sciences Inc.

  • 1 investor had already put money in when it filed.
  • The filing names 9 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Conexeu Sciences Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Conexeu Sciences Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (ir.conexeu.com).

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Conexeu Sciences Inc.. With no account yet, you sign up free and land on the result.

More on Conexeu Sciences Inc.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Conexeu Sciences Inc.: Raised $45K, Form D filed 2026-05-21
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/conexeu-sciences-inc-form-d-26000002
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Conexeu Sciences Inc. raised $45K — SEC Form D filing, May 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/conexeu-sciences-inc-form-d-26000002